ID
39866
Descripción
Study ID: 110399 Clinical Study ID: 110399 Study Title: A randomized, double blind, parallel group, placebo controlled 28 day study to investigate the safety, tolerability and pharmacodynamics of SB-656933 in subjects with cystic fibrosis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00903201 https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB656933, Placebo Trade Name: N/A Study Indication: Cystic Fibrosis The study consists of a screening, five study visits and a follow-up (time relative to Baseline in days): Visit 1: Screening, Day -28 to -16 Visit 2a: Day -7 to -4 Visit 2b: Day 1 Visit 3: Day 14 Visit 4: Day 21 Visit 5: Day 28 Visit 6: Early Withdrawal/ Follow-up, Day 35 to 42. From day 1 to day 28 the patients will receive daily doses. This document contains the Pharmacodynamics and Pharmacokinetics Blood form. It has to be filled in for V2b, V3, V5 and if required for logs/ repeats.
Link
https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201
Palabras clave
Versiones (2)
- 19/2/20 19/2/20 -
- 25/2/20 25/2/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
25 de febrero de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety, tolerability and pharmacodynamics of Elubrixin in cystic fibrosis patients, NCT00903201
Pharmacodynamics, Pharmacokinetics Blood
- StudyEvent: ODM
Descripción
Pharmacodynamics/ biomarkers
Alias
- UMLS CUI-1
- C0851347
- UMLS CUI-2
- C0005516
Descripción
If you will fill in this form for logs/ repeats, tick "Repeat". For all other visits tick "Pre-Dose".
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0178602
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C1302413
Descripción
00:00-23:59
Tipo de datos
time
Alias
- UMLS CUI [1]
- C4064021
Descripción
Only to be filled in for logs/ repeats.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1299222
Descripción
Pharmacokinetics Blood
Alias
- UMLS CUI-1
- C0031328
- UMLS CUI-2
- C0005767
Descripción
For Visit 2b all timepoints have to be filled in. For Visit 3 only Pre-Dose has to be filled in. For Visit 5 only Pre-Dose, 1 Hr and 4 Hr have to be filled in. If you will fill in this form for logs/ repeats, tick "Repeat".
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0178602
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005767
Descripción
00:00-23:59
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005767
Descripción
Only to be filled in for logs/ repeats.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1299222
Similar models
Pharmacodynamics, Pharmacokinetics Blood
- StudyEvent: ODM
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0005516 (UMLS CUI-2)
C0178602 (UMLS CUI [1,2])
C0005767 (UMLS CUI-2)
C0178602 (UMLS CUI [1,2])
C0031328 (UMLS CUI [1,2])
C0005767 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C0005767 (UMLS CUI [1,3])
Sin comentarios